Learning Objectives 

After completion of this module, you should be able to:

  • Assess your compliance with evidence-based measures for the assessment of patients with asthma
  • Select and implement appropriate interventions to improve compliance with the measures
  • Compare and contrast practice before and after the intervention(s) to identify possible improvements in the assessment of patients with asthma

Module Authors:

  • Giselle Mosnaim, MD MS FAAAAI – Activity Chair
    North Shore University Health System, Evanston IL
  • Stuart L. Abramson, MD PhD FAAAAI
    Shannon Medical Center, San Angelo TX
  • Caroline C. Horner, MD FAAAAI
    Washington University, St. Louis MO
  • John Oppenheimer, MD FAAAAI
    Pulmonary and Allergy Associates, Denville NJ
  • Matthew A. Rank, MD FAAAAI
    Mayo Clinic and Foundation, Scottsdale AZ
  • Kristin C. Sokol, MD
    Beth Israel Deaconess Medical Center, Brookline MA
  • Susan L. Symington, PA
    Northwest Asthma and Allergy Center, Seattle WA

Content Reviewers:

  • Thomas B. Casale, MD FAAAAI
    University of South Florida, Tampa FL
  • Michael Schatz, MD MS FAAAAI
    Kaiser Permanente, San Diego CA

CME/MOC Committee Reviewers:

  • Anne M. Ditto, MD FAAAAI
    Northwestern University, Chicago IL
  • Benjamin Prince, MD
    Nationwide Children’s Hospital, Columbus OH

AAAAI Staff:

  • Steven Folstein, MFA M.Ed.
    Director of Education
  • Lauri Sweetman
    Program Manager, Asthma-IQ
Faculty Disclosures 

Authors and Reviewers disclosed the following relevant financial relationships:

Dr. Mosnaim: consultant for Teva, Novartis, and Boehringer-Ingleheim; advisory board member for GlaxoSmithKline
Dr. Horner: NIH/NHLBI AsthmaNet research grant
Dr. Casale: advisory board member for Sanofi-Aventis, Teva, Aviragen, Aimmune, Novartis, Genentech, Boerhinger-Ingelheim, and AstraZeneca; consultant for Circassia

All other authors, reviewers, and staff disclosed no relevant financial relationships.

Accreditation Statement

The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this PI CME activity for a maximum of 20.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Allergy and Immunology MOC Statement

The American Board of Allergy and Immunology has approved this performance improvement module to meet the requirements for Part IV of their Maintenance of Certification (MOC) program.

CME for MIPS logo

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

Release and Renewal Dates

Original release date: November 1, 2017. Reviewed by Matthew Rank, MD FAAAAI on May 26, 2019. Valid for credit through December 15, 2020.